Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases
NCT03599752 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-01-09
Summary
This phase II trial studies how well chemotherapy and/or metastasectomy work in treating patients with colorectal adenocarcinoma that has spread to the lungs (metastases). Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Metastasectomy is a surgical procedure that removes tumors formed from cells that have spread from other places in the body. It is not yet known if chemotherapy and metastasectomy together works better in treating patients with metastatic colorectal adenocarcinoma with lung metastases.
Conditions
- Colorectal Adenocarcinoma
- Colorectal Carcinoma Metastatic in the Lung
- Stage IV Colorectal Cancer AJCC v8
- Stage IVA Colorectal Cancer AJCC v8
- Stage IVB Colorectal Cancer AJCC v8
- Stage IVC Colorectal Cancer AJCC v8
Interventions
- DRUG
-
Receive chemotherapy
- PROCEDURE
-
Metastasectomy
Undergo pulmonary metastasectomy
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Mara B. Antonoff, MD · M.D. Anderson Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-02
- Primary Completion
- 2030-01-31
- Completion
- 2030-01-31
- FDA Drug
- Yes
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer
NCT00004195 ·Status: COMPLETED ·Phase: PHASE2
-
Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
NCT00003543 ·Status: COMPLETED ·Phase: PHASE1
-
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
NCT02888743 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer
NCT03592641 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients
NCT01453257 ·Status: COMPLETED ·Phase: PHASE2
-
Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer
NCT00021268 ·Status: UNKNOWN ·Phase: PHASE1
-
S9923 R115777 in Treating Patients With Advanced Colorectal Cancer
NCT00005833 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
NCT04038619 ·Status: RECRUITING ·Phase: PHASE1
-
AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer
NCT00397878 ·Status: TERMINATED ·Phase: PHASE2
-
Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer
NCT00077259 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
NCT00559676 ·Status: COMPLETED ·Phase: PHASE4
-
Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer
NCT00016250 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma
NCT00097578 ·Status: COMPLETED
-
Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
NCT00551421 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer
NCT06275958 ·Status: RECRUITING ·Phase: PHASE3
-
Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
NCT00003485 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
NCT06637462 ·Status: RECRUITING ·Phase: NA
-
Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer
NCT06575725 ·Status: WITHDRAWN ·Phase: PHASE2
-
Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer
NCT00052507 ·Status: COMPLETED ·Phase: PHASE2
-
Systemic Therapy in Combination with Stereotactic Radiotherapy in Patients with Metastatic Colorectal Cancer Up to 10 Metastatic Sites
NCT05375708 ·Status: SUSPENDED ·Phase: PHASE2
-
A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer
NCT01729923 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.
NCT07263178 ·Status: RECRUITING
-
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
NCT04017650 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer
NCT00975897 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
NCT03803553 ·Status: RECRUITING ·Phase: PHASE3